03/06/2025
4:18 PM | Phathom Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2025
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2025
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
3:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:24 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:20 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:05 AM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:05 AM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
10:46 AM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
Get the Latest News and Ratings for PHAT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/07/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:12 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
11/05/2024
2:32 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G | |
11/04/2024
10:20 AM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
08/22/2024
3:05 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/19/2024
4:12 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
08/19/2024
4:13 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Phathom Pharmaceuticals (Subject)
| Form FWP | |
08/08/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
1:52 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:50 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
1:51 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
12:59 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/31/2024
5:37 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:34 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:33 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:43 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:44 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:47 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:14 PM | Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:18 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
5:10 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024
5:15 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
Ex CIA predicts 40% “double crash” – April 11 (Ad) The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology…
They’re studying something far more alien…
Something you’ve never seen before… Click here for my latest prediction before it’s taken offline. |
03/26/2024
3:05 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
